SinusLogic Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$1.3M
- Investors
-
3
SinusLogic General Information
Description
Manufacturer of medical devices intended for providing treatments to chronic rhinosinusitis patients. The company offers a sterile, single-use, long-term, surgically placed medical device composed of medical-grade polydimethylsiloxane, enabling medical professionals to access the ethmoid sinus for the delivery of saline.
Contact Information
Website
www.sinuslogic.comCorporate Office
- 4450 Arapahoe Road
- Suite 100
- Boulder, CO 80303
- United States
Corporate Office
- 4450 Arapahoe Road
- Suite 100
- Boulder, CO 80303
- United States
SinusLogic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 01-Aug-2024 | $1.3M | Completed | Generating Revenue | ||
| 5. Secondary Transaction - Private | 01-Aug-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 17-Dec-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 16-Oct-2014 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 16-Jul-2012 | $1.2M | $1.31M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 06-Apr-2011 | $110K | $110K | Completed | Generating Revenue |
SinusLogic Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series AA |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SinusLogic Patents
SinusLogic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3675780-B1 | Paranasal sinus fluid access implantation tools and assemblies | Active | 20-Sep-2017 | ||
| ES-3012747-T3 | Paranasal sinus fluid access implantation tools and assemblies | Active | 20-Sep-2017 | ||
| AU-2018338092-A1 | Paranasal sinus fluid access implantation tools, assemblies, kits and methods | Active | 20-Sep-2017 | ||
| AU-2018338092-B2 | Paranasal sinus fluid access implantation tools, assemblies, kits and methods | Active | 20-Sep-2017 | ||
| CA-3076375-A1 | Paranasal sinus fluid access implantation tools, assemblies, kits and methods | Active | 20-Sep-2017 | A61F9/00772 |
SinusLogic Signals
SinusLogic Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Buff Gold Ventures | Venture Capital | Minority | ||
| Louisiana Funds | Venture Capital | Minority | ||
| Skyland Capital | Venture Capital | Minority |
SinusLogic FAQs
-
When was SinusLogic founded?
SinusLogic was founded in 2011.
-
Where is SinusLogic headquartered?
SinusLogic is headquartered in Boulder, CO.
-
What is the size of SinusLogic?
SinusLogic has 6 total employees.
-
What industry is SinusLogic in?
SinusLogic’s primary industry is Therapeutic Devices.
-
Is SinusLogic a private or public company?
SinusLogic is a Private company.
-
What is the current valuation of SinusLogic?
The current valuation of SinusLogic is .
-
What is SinusLogic’s current revenue?
The current revenue for SinusLogic is .
-
How much funding has SinusLogic raised over time?
SinusLogic has raised $18.5M.
-
Who are SinusLogic’s investors?
Buff Gold Ventures, Louisiana Funds, and Skyland Capital have invested in SinusLogic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process